Teresa is the Director of Clinical and Regulatory Operations for BioMotiv, and brings more than 17 years of pharmaceutical industry experience with her to this role. She is responsible for overseeing all Clinical and Regulatory operational functions in support of the development and progression of compounds from pre-clinical through early phase clinical research.
Teresa has broad clinical research experience, across multiple therapeutic areas including cardiovascular, pulmonary, immunology, vaccines and oncology. Prior to joining BioMotiv, Teresa was the Director of Global Clinical Operations for a small CRO, and was responsible for all clinical trial management, project management and regional monitoring activities across the global organization. For many years, Teresa held roles in clinical trial management and clinical operations at companies such as GSK, Johnson & Johnson, and Novartis Vaccines.
Teresa has a BA degree in biology from Rutger’s University and has done post-graduate work in clinical pharmacology at Thomas Jefferson University.